Your browser doesn't support javascript.
loading
Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models.
Wong Te Fong, Anne-Christine; Thavasu, Parames; Gagrica, Sladjana; Swales, Karen E; Leach, Martin O; Cosulich, Sabina C; Chung, Yuen-Li; Banerji, Udai.
Afiliação
  • Wong Te Fong AC; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and The Royal Marsden, London, UK.
  • Thavasu P; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Gagrica S; Division of Cancer Therapeutics and Division of Clinical Studies, The Institute of Cancer Research and The Royal Marsden, London, UK.
  • Swales KE; IMED Oncology, AstraZeneca, Cancer Research UK Cambridge Institute, Cambridge, UK.
  • Leach MO; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Cosulich SC; Division of Cancer Therapeutics and Division of Clinical Studies, The Institute of Cancer Research and The Royal Marsden, London, UK.
  • Chung YL; Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and The Royal Marsden, London, UK.
  • Banerji U; IMED Oncology, AstraZeneca, Cancer Research UK Cambridge Institute, Cambridge, UK.
Oncotarget ; 8(69): 113874-113884, 2017 Dec 26.
Article em En | MEDLINE | ID: mdl-29371953
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido